BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26105515)

  • 1. KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
    Partl R; Fastner G; Kaiser J; Kronhuber E; Cetin-Strohmer K; Steffal C; Böhmer-Breitfelder B; Mayer J; Avian A; Berghold A
    Support Care Cancer; 2016 Feb; 24(2):523-528. PubMed ID: 26105515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.
    Morris SL; Low SH; A'Hern RP; Eisen TG; Gore ME; Nutting CM; Harrington KJ
    Br J Cancer; 2004 Aug; 91(5):829-33. PubMed ID: 15305201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
    J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
    Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
    Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
    Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting prognosis of short survival time after palliative whole-brain radiotherapy.
    Miyazawa K; Shikama N; Okazaki S; Koyama T; Takahashi T; Kato S
    J Radiat Res; 2018 Jan; 59(1):43-49. PubMed ID: 29069502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with brain metastasis from non-small cell lung cancer treated with whole-brain radiotherapy.
    Harada H; Asakura H; Ogawa H; Mori K; Takahashi T; Nakasu Y; Nishimura T
    J Cancer Res Ther; 2016; 12(1):267-70. PubMed ID: 27072249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
    Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
    World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors After Whole-brain Radiotherapy Alone for Brain Metastases from Malignant Melanoma.
    Rades D; Sehmisch L; Janssen S; Schild SE
    Anticancer Res; 2016 Dec; 36(12):6637-6640. PubMed ID: 27919995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy.
    Anami S; Doi H; Nakamatsu K; Uehara T; Wada Y; Fukuda K; Inada M; Ishikawa K; Kanamori S; Nishimura Y
    J Radiat Res; 2019 Mar; 60(2):257-263. PubMed ID: 30576550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors.
    Lee WY; Cho DY; Lee HC; Chuang HC; Chen CC; Liu JL; Yang SN; Liang JA; Ho LH
    J Clin Neurosci; 2009 May; 16(5):630-4. PubMed ID: 19269828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.